AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7769301 — intervention group
Group type: EXPERIMENTAL
Intervention: Menfegol foaming tablets used once every other day
Number of subjects: 125
Study 7769301 — intervention group
Group type: EXPERIMENTAL
Intervention: Menfegol foaming tablets used 1 time a day
Number of subjects: 125
Study 7769301 — intervention group
Group type: EXPERIMENTAL
Intervention: Menfegol foaming tablets used 2 times a day
Number of subjects: 125
Study 7769301 — intervention group
Group type: EXPERIMENTAL
Intervention: Menfegol foaming tablets used 4 times a day
Number of subjects: 125
Study 7769301 — intervention group
Group type: EXPERIMENTAL
Intervention: Menfegol foaming tablets used 8 times a day
Number of subjects: 125
Study 7769301 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets used < 8 times daily
Number of subjects: 125
Study 7769301 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets used 8 times daily
Number of subjects: 125
Study 2162749 — intervention group
Group type: EXPERIMENTAL
Intervention: (R,S)-propafenone hydrochloride 300 mg
Number of subjects: 8
Study 2162749 — intervention group
Group type: EXPERIMENTAL
Intervention: (S)-propafenone hydrochloride 150 mg
Number of subjects: 8
Study 2162749 — intervention group
Group type: COMPARATOR
Intervention: (R)-propafenone hydrochloride 150 mg
Number of subjects: 8
Study 2162749 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-propafenone 3 x 10(−6) mol/L
Number of subjects: 8
Study 2162749 — intervention group
Group type: EXPERIMENTAL
Intervention: (S)-propafenone 3 x 10(−6) mol/L
Number of subjects: 8
Study 383553 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaprim (rifampicin 600 mg plus trimethoprim 160 mg, single daily dose at 10 p.m.)
Number of subjects: 42
Study 383553 — intervention group
Group type: COMPARATOR
Intervention: Cotrimoxazole (two tablets b.i.d.)
Number of subjects: 42
Study 31551097 — intervention group
Group type: EXPERIMENTAL
Intervention: SCOTT (social-cognitive training)
Number of subjects: 48
Study 31551097 — intervention group
Group type: COMPARATOR
Intervention: Non-social computer training (active control)
Number of subjects: 48
Study 31794034 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based deliberate practice
Number of subjects: 132
Study 31794034 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 132
Study 28733854 — intervention group
Group type: EXPERIMENTAL
Intervention: Support to stay in school (tuition, uniform, nurse visits)
Number of subjects: 412
Study 28733854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse visits
Number of subjects: 412
Study 28733854 — intervention group
Group type: EXPERIMENTAL
Intervention: Attending boarding school
Number of subjects: 412
Study 28733854 — intervention group
Group type: EXPERIMENTAL
Intervention: School fees and uniforms
Number of subjects: 412
Study 28733854 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 412
Study 26108785 — intervention group
Group type: EXPERIMENTAL
Intervention: R118
Number of subjects: 24
Study 26108785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 23864006 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Blalock‐Taussig shunt
Number of subjects: 549
Study 23864006 — intervention group
Group type: COMPARATOR
Intervention: Right ventricle‐pulmonary artery shunt
Number of subjects: 549
Study 23864006 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention for recoarctation (catheter based or surgical)
Number of subjects: 549
Study 21551025 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited health literacy defined as a REALM score ≤60
Number of subjects: 288
Study 21551025 — intervention group
Group type: COMPARATOR
Intervention: Demographic and clinical characteristics
Number of subjects: 288
Study 21551025 — intervention group
Group type: COMPARATOR
Intervention: Age, gender, serologic values, dialysis adequacy, overall symptom burden, quality of life, depression
Number of subjects: 288
Study 19196673 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine, oxaliplatin, and bevacizumab (CB regimen)
Number of subjects: 755
Study 19196673 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine, oxaliplatin, bevacizumab plus weekly cetuximab (CBC regimen)
Number of subjects: 755
Study 19196673 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab in patients with mutated KRAS gene
Number of subjects: 755
Study 17223390 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain recall assessed by treating physician
Number of subjects: 70
Study 17223390 — intervention group
Group type: COMPARATOR
Intervention: Pain recall assessed by research assistant
Number of subjects: 70
Study 15212355 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix proteins (EMD)
Number of subjects: 75
Study 15212355 — intervention group
Group type: COMPARATOR
Intervention: Guided tissue regeneration (GTR)
Number of subjects: 75
Study 11450927 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacy consultation for head lice treatment
Number of subjects: 0
Study 9503220 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin administration over a 10-day period
Number of subjects: 50
Study 9503220 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control group)
Number of subjects: 50
Study 7800129 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidrug chemotherapy (6‐thioguanine, dibromodulcitol, procarbazine, 1‐(2‐chloroethyl)‐3‐cyclohexyl‐1‐nitrosourea, 5‐fluorouracil, and hydroxyurea)
Number of subjects: 51
Study 7800129 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidrug chemotherapy
Number of subjects: 51
Study 7800129 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater surgical debulking and smaller postoperative tumor volumes
Number of subjects: 51
Study 7800129 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater myelotoxicity
Number of subjects: 51
Study 3054094 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac, 150 mg/day
Number of subjects: 417
Study 3054094 — intervention group
Group type: COMPARATOR
Intervention: Aspirin, 3.6 g/day
Number of subjects: 417
Study 3054094 — intervention group
Group type: COMPARATOR
Intervention: Naproxen, 1000 mg/day
Number of subjects: 417
Study 29974228 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin with LipiSperse® delivery system
Number of subjects: 18
Study 29974228 — intervention group
Group type: COMPARATOR
Intervention: Raw curcumin product
Number of subjects: 18
Study 27849639 — intervention group
Group type: EXPERIMENTAL
Intervention: WeCareAdvisor (web-based caregiver support tool)
Number of subjects: 38
Study 25414173 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin 1 ng/kg per minute
Number of subjects: 90
Study 25414173 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin 2 ng/kg per minute
Number of subjects: 90
Study 25414173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 23295274 — intervention group
Group type: EXPERIMENTAL
Intervention: EQUIP training for endoscopists
Number of subjects: 15
Study 23295274 — intervention group
Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 15
Study 22104620 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased levels of norepinephrine
Number of subjects: 0
Study 22104620 — intervention group
Group type: EXPERIMENTAL
Intervention: Infarction of the anterior MCA cortex
Number of subjects: 0
Study 22104620 — intervention group
Group type: EXPERIMENTAL
Intervention: Large stroke volume and lesions affecting distinct regions of the MCA cortex
Number of subjects: 0
Study 22104620 — intervention group
Group type: EXPERIMENTAL
Intervention: Sympathetic nerve system (SNS) activation
Number of subjects: 0
Study 22104620 — intervention group
Group type: COMPARATOR
Intervention: Stroke severity and stroke volume
Number of subjects: 0
Study 18512093 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia cap
Number of subjects: 20
Study 18512093 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prehospital cooling)
Number of subjects: 20
Study 17000786 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (1 microg kg(‐1) h(‐1))
Number of subjects: 40
Study 17000786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 12914551 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 micro g/kg of APO
Number of subjects: 18
Study 12914551 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micro g/kg of APO
Number of subjects: 18
Study 12914551 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micro g/kg of APO
Number of subjects: 18
Study 10740546 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anaesthesia
Number of subjects: 84
Study 10740546 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane anaesthesia
Number of subjects: 84
Study 10740546 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anaesthesia
Number of subjects: 84
Study 10740546 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane anaesthesia
Number of subjects: 84
Study 10740546 — intervention group
Group type: COMPARATOR
Intervention: Comparison of inhalation anaesthetics
Number of subjects: 84
Study 8752016 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine 100 mg/day
Number of subjects: 40
Study 8752016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 1281905 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating COPP/ABVD chemotherapy +/‐ radiotherapy
Number of subjects: 297
Study 1281905 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage treatment
Number of subjects: 297
Study 1281905 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation alone
Number of subjects: 297
Study 1281905 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional salvage treatment
Number of subjects: 297
Study 1281905 — intervention group
Group type: COMPARATOR
Intervention: High-dose chemotherapy with subsequent autologous bone marrow transplantation (HDC/ABMT)
Number of subjects: 297
Study 6726600 — intervention group
Group type: EXPERIMENTAL
Intervention: Fake-aggressive group
Number of subjects: 58
Study 6726600 — intervention group
Group type: EXPERIMENTAL
Intervention: Fake-nonaggressive group
Number of subjects: 58
Study 6726600 — intervention group
Group type: COMPARATOR
Intervention: Standard-instruction control group
Number of subjects: 58
Study 31248067 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual Western‐style diet enriched with 60 g/day of a mixture of nuts (nut group; n = 43)
Number of subjects: 83
Study 31248067 — intervention group
Group type: COMPARATOR
Intervention: Usual Western‐style diet avoiding nuts (control group; n = 40)
Number of subjects: 83
Study 29952993 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Needling + Exercise
Number of subjects: 20
Study 29952993 — intervention group
Group type: COMPARATOR
Intervention: Sham Dry Needling + Exercise
Number of subjects: 20
Study 27116006 — intervention group
Group type: EXPERIMENTAL
Intervention: PRET device (automated transfer pump)
Number of subjects: 599
Study 27116006 — intervention group
Group type: COMPARATOR
Intervention: Manual transfer
Number of subjects: 599
Study 27116006 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen-thawed embryo transfers with PRET
Number of subjects: 599
Study 27116006 — intervention group
Group type: COMPARATOR
Intervention: Frozen-thawed embryo transfers with manual transfer
Number of subjects: 599
Study 25018121 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly dulaglutide (1.5 mg)
Number of subjects: 599
Study 25018121 — intervention group
Group type: COMPARATOR
Intervention: Once-daily liraglutide (1.8 mg)
Number of subjects: 599
Study 25018121 — intervention group
Group type: COMPARATOR
Intervention: Comparison of dulaglutide vs liraglutide
Number of subjects: 599
Study 25018121 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly dulaglutide
Number of subjects: 599
Study 25018121 — intervention group
Group type: COMPARATOR
Intervention: Once-daily liraglutide
Number of subjects: 599
Study 25018121 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 599
Study 21915624 — intervention group
Group type: EXPERIMENTAL
Intervention: GMA adjusted to patients' body weight (BW), 60 mL/kg
Number of subjects: 60
Study 21915624 — intervention group
Group type: COMPARATOR
Intervention: Routine GMA (fixed at 30 mL/min × 60 min)
Number of subjects: 60
Study 21915624 — intervention group
Group type: EXPERIMENTAL
Intervention: GMA adjusted to patients' BW
Number of subjects: 60
Study 21915624 — intervention group
Group type: COMPARATOR
Intervention: Routine GMA
Number of subjects: 60
Study 20613676 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D intake (less than 100, 100 to 199, 200 to 399, 400 to 599, and 600 or greater IU/day)
Number of subjects: 808
Study 20613676 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake (less than 500, 500 to 749, 750 to 999, 1,000 to 1,199, and 1,200 or greater mg/day)
Number of subjects: 808
Study 20613676 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental vitamin D use
Number of subjects: 808
Study 17283364 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine and cyclophosphamide (FC arm)
Number of subjects: 278
Study 17283364 — intervention group
Group type: COMPARATOR
Intervention: Fludarabine (F arm)
Number of subjects: 278
Study 16054549 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran flour
Number of subjects: 12
Study 16054549 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran crisp
Number of subjects: 12
Study 16054549 — intervention group
Group type: COMPARATOR
Intervention: Glucose load
Number of subjects: 12
Study 12362376 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone Morphing method for TKA
Number of subjects: 35
Study 12362376 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopic assessment of soft-tissue balancing
Number of subjects: 35
Study 11603418 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone at a mean dose of 25 mg/day
Number of subjects: 0
Study 8996753 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine withdrawal (tapered over 1 year)
Number of subjects: 172
Study 8996753 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (continued)
Number of subjects: 172
Study 1592448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chloride (200 mmol/day)
Number of subjects: 15
Study 1592448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate (200 mmol/day)
Number of subjects: 15
Study 1592448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chloride and sodium citrate (200 mmol/day)
Number of subjects: 15
Study 1592448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 6370155 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative carcinoembryonic antigen (CEA) levels
Number of subjects: 945
Study 30288843 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) at 60 seconds
Number of subjects: 51
Study 30288843 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (ECC) at 15 seconds
Number of subjects: 51
Study 30288843 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 51
Study 30288843 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (ECC)
Number of subjects: 51
Study 29727028 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (post-tetanic count 1-2 maintained and reversed with sugammadex)
Number of subjects: 64
Study 29727028 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (train-of-four count 1-2 maintained and antagonised with neostigmine)
Number of subjects: 64
Study 29727028 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade
Number of subjects: 64
Study 29727028 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade
Number of subjects: 64
Study 27389114 — intervention group
Group type: EXPERIMENTAL
Intervention: Nervomatrix Soleve® auto‐targeted neurostimulation device providing TENS-stimulation and mechanical pressure
Number of subjects: 39
Study 27389114 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (Nervomatrix Soleve® auto‐targeted neurostimulation device providing mechanical pressure alone without current)
Number of subjects: 39
Study 25009402 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal gastrectomy with jejunal interposition (PGJI)
Number of subjects: 76
Study 25009402 — intervention group
Group type: COMPARATOR
Intervention: Total gastrectomy with Roux-en-Y anastomosis (TGRY)
Number of subjects: 76
Study 23217501 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytoestrogen supplementation (Bioos, Montegiorgio, Italy)
Number of subjects: 66
Study 23217501 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 66
Study 20919776 — intervention group
Group type: EXPERIMENTAL
Intervention: High epistemic motivation (mild vs. intense time pressure; presence vs. absence of process accountability)
Number of subjects: 3
Study 20919776 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosocial motives
Number of subjects: 3
Study 20919776 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming of originality norms
Number of subjects: 3
Study 20919776 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming of appropriateness norms
Number of subjects: 3
Study 20919776 — intervention group
Group type: EXPERIMENTAL
Intervention: Epistemic motivation
Number of subjects: 3
Study 18347893 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed message (one shot)
Number of subjects: 237
Study 18347893 — intervention group
Group type: COMPARATOR
Intervention: Gain-framed message (one shot)
Number of subjects: 237
Study 18347893 — intervention group
Group type: COMPARATOR
Intervention: Loss-framed message (six shots)
Number of subjects: 237
Study 18347893 — intervention group
Group type: COMPARATOR
Intervention: Gain-framed message (six shots)
Number of subjects: 237
Study 16251559 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon anesthesia
Number of subjects: 42
Study 16251559 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 42
Study 12788862 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide (125 mg/d) and Metformin (1275 mg/d)
Number of subjects: 30
Study 12788862 — intervention group
Group type: COMPARATOR
Intervention: Control phase (3 months, n = 14)
Number of subjects: 30
Study 10343482 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses in CQI teams
Number of subjects: 0
Study 8951297 — intervention group
Group type: EXPERIMENTAL
Intervention: IV immune globulin treatment
Number of subjects: 127
Study 29846630 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine
Number of subjects: 185
Study 29846630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 27911904 — intervention group
Group type: EXPERIMENTAL
Intervention: Dressing removed on the first postoperative day (group I)
Number of subjects: 200
Study 27911904 — intervention group
Group type: COMPARATOR
Intervention: Dressing removed on the sixth postoperative day (group II)
Number of subjects: 200
Study 24863728 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC)
Number of subjects: 15
Study 24863728 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 15
Study 23147280 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasoalveolar molding (NAM)
Number of subjects: 28
Study 23147280 — intervention group
Group type: COMPARATOR
Intervention: Passive orthopedic method (Hotz plate, HP)
Number of subjects: 28
Study 21178937 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (16 weeks, 3 days/week, 90 min, 50‐80% VO2max)
Number of subjects: 65
Study 21178937 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 65
Study 21178937 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise program
Number of subjects: 65
Study 21178937 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study 17215848 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 80
Study 17215848 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 160 mg
Number of subjects: 80
Study 17215848 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg plus Valsartan 160 mg
Number of subjects: 80
Study 15769714 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-slice multislice computed tomographic (MSCT) angiography
Number of subjects: 50
Study 12132278 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic analgesics combined with on demand medication (group 2)
Number of subjects: 215
Study 12132278 — intervention group
Group type: COMPARATOR
Intervention: On demand medication exclusively (group 1)
Number of subjects: 215
Study 9660994 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (120 mg daily) for 6 months
Number of subjects: 29
Study 9660994 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (120 mg daily) for 12 months
Number of subjects: 29
Study 9660994 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (120 mg daily) with or without concomitant antiretroviral agents
Number of subjects: 29
Study 9660994 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (120 mg daily)
Number of subjects: 29
Study 7648767 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release formulation of racemic verapamil (240 mg)
Number of subjects: 12
Study 7648767 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release formulation of racemic verapamil (240 mg)
Number of subjects: 12
Study 2668365 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride (NaF) dentifrice
Number of subjects: 3290
Study 2668365 — intervention group
Group type: COMPARATOR
Intervention: Sodium monofluorophosphate (Na2PO3F) dentifrice
Number of subjects: 3290
Study 1272739 — intervention group
Group type: EXPERIMENTAL
Intervention: Tone or music stimuli with soft or loud intensities for 5 sec. or 30 sec. adaptation periods.
Number of subjects: 64
Study 1272739 — intervention group
Group type: EXPERIMENTAL
Intervention: Tone or music stimuli with soft or loud intensities for 5 min. adaptation periods.
Number of subjects: 64
Study 31672070 — intervention group
Group type: EXPERIMENTAL
Intervention: BBTI (Brief Behavioral Treatment for Insomnia)
Number of subjects: 40
Study 31672070 — intervention group
Group type: COMPARATOR
Intervention: HEP (Healthy Eating Program)
Number of subjects: 40